Chronic Orofacial PainNCT06932406
Orofacial Pain Self-management: Personality Moderation Effect
A study testing Self-management intervention and Clinical Practice Guideline Intervention in people with Chronic Orofacial Pain and Temporomandibular Disorder (TMD), run by Fundación Universidad Católica de Valencia San Vicente Mártir at 1 site in Spain.
Trial summary
The objective of this clinical trial is to study the effect of self-management on pain perception in patients with chronic orofacial pain and temporomandibular disorders (TMD) comparing it with the conventional treatment proposed by the TMD clinical practice guidelines. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Chronic Orofacial Pain, Temporomandibular Disorder (TMD), Temporomandibular Disorders (TMD)
- What is being tested?
- Self-management intervention and Clinical Practice Guideline Intervention
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 98 participants
- Where
- 1 siteSpain
- Study dates
- 28 Nov 2025to 24 May 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- The patient presents TMDs diagnosed according to the CD/TMD classification.
- Age between 18 and 65.
- Presence of pain in mandibular, temporal, facial, peri-auricular and/or auricular regions.
- Presence of chronic orofacial pain. Defined by the ICD-11 as orofacial pain or headache that occurs for more than two hours a day for 50% of the days of the last three months.
- Orofacial pain is related to TMDs according to the International Classification of Headaches.
- Moderate pain intensity, corresponding to a weekly average of at least 30 mm on a 100 mm VAS (validated representation of moderate pain on the VAS scale = 31-54 mm)
Who cannot join
- Concomitant rheumatic systemic pathologies.
- History of trauma or recent surgical intervention in the head, face, neck or chest.
- Presence of intraoral infections or odontogenic pain.
- Headache of neuropathic origin (trigeminal neuralgia, Arnold neuralgia, etc.).
- Being receiving therapy (except rescue pharmacological therapy) for this disorder or pain.
- Cognitive impairment that prevents the follow-up of an educational program (determined through the MoCA questionnaire)
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Spain1 site, 1 recruiting
- Recruiting
Catholic Univerity of Valencia
Valencia, Valencia, 46001
Marta Martinez Soler, PhD Student, +34 609310056, marta.martinez@ucv.es
Juan V-M Vicente Mampel, PhD, +34 674177877, juan.vicente@ucv.es
About this study
Official title: Orofacial Pain Self-management: Personality Moderation Effect - Randomized Clinical Trial
The objective of this clinical trial is to study the effect of self-management on pain perception in patients with chronic orofacial pain and temporomandibular disorders (TMD) comparing it with the conventional treatment proposed by the TMD clinical practice guidelines. It also evaluates its effect on function and various psychosocial variables.
As a secondary objective, this work proposes to study the variability between patients, in terms of personality factors, as moderators of the effect of treatment on pain perception. Including in the proposed statistical models certain covariates such as perception and/or coping with stress, anxiety and other psychosocial variables.
This is a randomized clinical trial with two intervention groups and three measurement times (T0; pre-intervention, T1; post-5 weeks and T2; post-6 months). The experimental group will be applied a protocol based on self-management, which includes: therapeutic education, cognitive-behavioral tools, therapeutic exercise of the temporomandibular region, mind-body strategies and modifications of aspects related to lifestyle. The control group will carry out an intervention program based on the Clinical Practice Guidelines for the Management of Temporomandibular Joint Disorders. Therefore, using a set of tools based on therapeutic education, cognitive-behavioral tools for bruxism and other parafunctional habits, temporomandibular region exercises and manual therapy.
Read the detailed description
Temporomandibular disorders (TMD) are the most common cause of chronic orofacial pain and encompass a range of syndromes affecting the masticatory muscles and temporomandibular joints (TMJ). Approximately 9-13% of the population experiences orofacial pain related to TMD. The high complexity, multifactorial nature, recurrence, and long duration of chronic pain increase the need for approaches focused on a multi-component management, based on learning strategies and coping skills, self-efficacy, and self-care. These approaches can be classified as self-management interventions, and their multifactorial nature makes them suitable for application and teaching by various health professionals. Within this multifactoriality, previous studies have shown that the patient's personality influences the occurrence and progression of chronic pain. The objective of this study is to evaluate a comprehensive self-management program in patients with chronic orofacial pain to assess its effect on pain perception and other psychosocial and functional variables, and subsequently analyze the moderation of factors related to the patient's personality on the intervention outcomes.
It is hypothesized that the self-management-based treatment is effective in reducing pain perception in the short and medium term, and that personality is a moderating factor for the intervention's effect.
The study will be conducted on 98 subjects aged 18 to 65, diagnosed with TMD and chronic orofacial pain. The intervention will last for 10 weeks with 5 sessions of application and 3 sessions of evaluation (pre-intervention; during the session time for the first intervention application session, post-5 weeks during the session time for the last intervention application session, and post-6 months; in an extra session dedicated solely to making the evaluation record). Each intervention session will be held once every two weeks. Results will be assessed using the EVA and GCPS questionnaires (pain), PCS (catastrophizing), TSK/TMD/S (kinesiophobia), FABQ (fear-avoidance), MFIQ (mandibular dysfunction), CPSS (self-efficacy), MMO (mandibular opening), Borg (perceived fatigue), BFQ (personality), CLCD (pain locus), COPE28 (stress coping), PSS (stress perception), STAI (anxiety), pressure algometry (pain threshold), intra-articular sound quantification, and treatment-seeking behavior.
All variables will be taken in triplicate at all three measurement times with the exception of the personality-related variable (BFQ). A descriptive statistical analysis of all variables in each of the intervention groups will be performed. To analyse the effect of the intervention on pain and the other secondary variables, a repeated-means ANOVA analysis will be performed between the self-management group (GSelfManagement) and the group based on the clinical practice guideline (GGuide). To examine whether variation in pain at follow-up is influenced by personality variables and/or the psychosocial variables kinesiophobia, catastrophising thoughts, fear-avoidance, type of pain control, perception of stress and anxiety, and stress coping, a moderation and mediation analysis will be performed. This analysis determines whether the effect size of a causal variable X (VAS and GCPS, MFIQ, MMO and VAS Fatigue) on outcome Y (GGuide and GSelfManagement), depends on a moderating or mediating variable W (i.e., kinesiophobia, catastrophizing, fear-avoidance, stress and anxiety perception, stress coping, personality and type of pain control). The degree of significance will be set at p<0.05. All analyses will be performed using statistical analysis software (SPSS 24 Inc, Chicago, Illinois, USA and The PROCESS macro for SPSS).
- Conditions
- Chronic Orofacial Pain, Temporomandibular Disorder (TMD), Temporomandibular Disorders (TMD), Temporomandibular Dysfunction (TMD)
- Being tested
- Self-management intervention, Clinical Practice Guideline Intervention
- Keywords
- Temporomandibular disorder, Orofacial pain, Self-management, self-efficacy, therapeutic exercise, therapeutic education, cognitive behavioral, mind-body techniques, Lifestyle modification training, manual therapy, personality, psychosocial, biopsychosocial, physiotherapy
- Medical subject headings
- Temporomandibular Joint Disorders, Facial Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Self-management interventionOther
Also called GSelf-Management, GS-M
This intervention will implement a self-management protocol. It will consist in 5 strategy levels: educational concepts and dynamics, cognitive behavioural tools and processes, therapeutic exercise of the orofacial region, guidelines and strategies for lifestyle modification and mindbody tools.
Several of the above 5 strategies will be employed in each session. Education will include TMD concepts, pain neurophysiology, contextualisation of pain in terms of perceived stress, anxiety and others. Exercises will aim to train motor control, strength and mobility. Cognitive behavioural tools will be used to modulate pain relationship through behaviour modification. Processes such as cognitive distraction, gradual exposure to movement or the scheduling of self-care activities will be used. Mindbody strategies such as relaxation exercises and pain acceptance will seek to reduce the patient's frustration with pain. Structured guidelines will be included to achieve desirable lifestyle changes.
Clinical Practice Guideline InterventionOther
Also called GClinical Practice Guideline, GCPG
Following the guidelines, 5 sessions of education, cognitive behavioural tools, jaw exercises and manual therapy will be conducted.
The educational sessions will teach about TMD and basic pain concepts. A single type of cognitive behavioural tool will be employed. The aim will be to decrease bruxing and parafunctional activity during wakefulness. This will be done by training the jaw relaxation position, which will then be generalised to activities of daily living with the help of some conditioning through positive and negative reinforcement. Exercise activities will aim to train motor control, strength and mobility. Manual therapy will be carried out in the orofacial region by means of soft tissue techniques and joint mobilisation.
| Study group | Role | What they receive |
|---|---|---|
| Self-management Group | Experimental | This group will implement a protocol based on self-management consisting of 5 levels of strategy: educational concepts and dynamics, cognitive behavioural tools, therapeutic exercise of the orofacial region, guidelines and strategies for lifestyle modification and mindbody tools. This protocol was developed by conducting a previous Scoping Review abouts application methods of selfmanagement in orofacial region. The intervention will be carried out in 5 total sessions of 45-60 minutos over 10 weeks. Receives: Other: Self-management intervention |
| Clinical Practice Guideline Group | Active comparator | The protocol will be based on the Clinical Practice Guideline for the Management of Temporomandibular Disorders 2021. Following the guideline, there will be 5 sessions of pathology and pain education, cognitive behavioural tools for bruxism and parafunctional habits, jaw exercises for motor control, mobility and strength, and manual therapy. The intervention will be carried out in 5 total sessions of 45-60 minutos over 10 weeks. Receives: Other: Clinical Practice Guideline Intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Visual Analogue Scale (VAS)
Pain intensity assessment instrument consisting of a 10-centimetre horizontal line numbered from 0 to 10, where 0 represents no pain and 10 represents the greatest unimaginable pain. The patient must mark on the line the point that indicates the intensity of his or her pain and then it is measured with a millimetre ruler. The intensity is expressed in centimetres or millimetres. If reporting a score on this scale, it is important to include the minimum and maximum values (0 and 10, respectively), as well as clarify that higher scores represent worse pain intensity. This tool has a high reliability, with an Internal Consistency (IC) of 0.97.
Measured: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.
Chronic Pain Grading Scale 2.0 Spanish Version (GCPS)
Quantitative assessment scale of chronic pain that evaluates the degree of pain using 8 items, quantifying the number of days of pain in the last 6 months, current pain, average and maximum monthly pain and pain and limitation in ADL, social and occupational activities. Each item measures the score on an 11-point Likert scale, with a total range from 0 to 70 points. The tool has an internal consistency, represented by Cronbach's α coefficient, of 0.87 (95% CI, 0.83-0.92). If reporting a score on this scale, it is important to include the minimum and maximum values (0 and 70, respectively), as well as clarify that higher scores represent worse outcomes.
Measured: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.
Secondary outcomes (15)
Demographic data
A standardised questionnaire will be used to collect information on age, sex, profession, concomitant conditions, drugs used (number, name and category).
Measured: These data will be collected pre-intervention.
Pain Catastrophizing Scale (PCS)
A scale that assesses catastrophic thoughts, consisting of 3 dimensions: rumination (constant worry and inability to inhibit pain-related thoughts), magnification (exaggeration of the unpleasantness of pain situations and expectations of negative consequences) and helplessness (inability to cope with painful situations). It consists of 13 items with a five-point Likert-type response scale (0 = Not at all; 4 = All the time), with scores ranging from 0 to 52. High scores indicate a greater presence of catastrophic thoughts.
This tool has an internal consistency (Cronbach's α) of 61.8%->70%.
Measured: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.
The Tampa Scale of Kinesiophobia for Temporomandibular Disorders Versión Español (TSK11-TMD-S)
Scale assessing kinesiophobia or fear of movement or injury in patients with TMD.
The scale consists of a total of 11 items. In each of the items, the user must indicate his or her degree of agreement with each of the statements presented. In this way, it is scored using a Likert-type scale from 1 (totally disagree) to 4 (totally agree), with higher scores being indicators of greater fear of movement.
It has an Internal Consistency (Cronbach's α) of 0.843.
Measured: It will be used in pre-intervention, post-5 weeks and post-6 months analyses.
Fear-Avoidance Beliefs Questionnaire (FABQ)
It is a self-administered questionnaire that assesses the patient's fear-avoidance beliefs about physical activity and work. It assesses activities of daily living, behaviour, functional mobility, general health, participation, mental health, motivation, occupational performance, pain, personality, quality of life, self-efficacy, stress and coping. It consists of 16 items in which the patient scores his or her degree of agreement or disagreement with the statement proposed in each item, using a 7-point Linkert-type scale. Where 0 symbolises complete disagreement and 6 complete agreement. The maximum score that can be obtained is 96 points, with higher scores indicating higher fear-avoidance beliefs. It consists of two subscales: the work subscale (FABQw) with 7 questions and a maximum score of 42 points, and the physical activity subscale (FABQpa) with 4 questions and a maximum score of 24.
ICC=0.97,FABQpa CI=0.77,FABQw=0.88. The total maximum score that can be obtained is 96 points
Measured: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.
The Mandibular Function Impairment Questionnaire (MFIQ)
To assess the perception of jaw function. Consists of two dimensions of 17 items in total that assess the degree of disability of various specific jaw functions. Each item is scored on a scale from 0 to 4, where 0 represents no difficulty and 4 represents extreme difficulty in performing a specific task. The sum results in a scale from 0 to 68, where higher scores represent a greater degree of disability.
The overall Internal Consistency of the scale is Cronbach's α =0.94, with Cronbach's α =0.87 for the first dimension and Cronbach's α =0.92 for the second dimension.
Measured: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.
Máxima apertura de la boca (MMO)
Quantification of the maximum jaw opening distance by measuring the upper and lower interincisive space during maximum jaw opening with a caliper (in millimetres). Three consecutive measurements shall be taken and the average of the three shall be recorded. It shall be measured in two ways: active maximum mandibular opening (MMO) and comfortable maximum opening (MCO). This type of measurement is frequently used in other similar articles.
Measured: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.
Intra-articular sounds
The presence and type of intra-articular sounds will be confirmed pre-intervention by the investigator collecting the data using a stethoscope placed over the mandibular condyle during the exploration of TMJ movement.
The procedure used to subjectively analyse intra-articular sounds has been described in other studies previously. To quantify the intensity of intra-articular sounds a numerical scale (NRS 0-10) will be used, the frequency will be reported by selecting one of the following options: 0 No joint sounds, 1 Joint sounds once or twice/week, 2 Joint sounds three/four times per week, 3 Joint sounds ≥ five times/week.
Measured: To be used in pre-intervention, post-5 weeks and post-6 months analyses.
Borg Scale
Exercise fatigue will be assessed using the Borg Scale, which has been used in other research to measure fatigue in different physical exercise contexts. This scale of perceived exertion measures the degree of effort that the individual perceives when doing a given exercise on a numerical scale from 0 to 10, where 0 is total rest and 10 is maximum effort. This tool will be used during each of the exercise sessions to ensure that the programmed intensity is met.
Measured: It will be collected during each of the exercise sessions to check compliance with the intensity of the exercises. The data will not be processed statistically.
Big Five Personality Test (BFQ)
The Big Five (BFQ) is a five-factor model to describe personality.. It uses a Likert-type scale consisting of 132 questions with five response options ranging from 'completely false for me' to 'completely true for me'. It identifies the five fundamental dimensions for describing and assessing personality (open-mindedness, emotional stability, responsibility, agreeableness, energy) and their respective sub-dimensions (openness to experience, openness to culture, impulse control, emotion control, perseverance, conscientiousness, friendliness, cooperation, dominance, dynamism). The Internal Consistency of Cronbach's alpha test has a significant value of 0.874 for the five scales and the ten subscales. When reporting a score on the BFQ, the total score ranges from 132 to 660, with higher scores indicating greater alignment with the positive characteristics of each personality dimension. Higher scores generally reflect better outcomes in terms of personality traits associated with positive
Measured: This tool will be used in the pre-intervention measurement.
Pain Locus of Control Questionnaire (CLCD)
The instrument consists of 33 items divided into three subscales assessing: (a) internal locus of control, which refers to people's beliefs about whether their pain is influenced by personal actions ('I can prevent pain if I avoid certain situations that make me nervous'; Cronbach's α = 0. 86); (b) locus of control by chance, determined by the degree to which a person believes that their pain is due to chance ('my pain cannot be controlled'; Cronbach's α = 0.84); and (c) locus of control by health professionals under the belief that their pain will be relieved by health professionals ('my doctor's treatment can help me reduce my pain'; Cronbach's α = 0.88). Responses to the instrument were made on a five-point scale, ranging from strongly disagree to strongly agree. Higher scores on the scale indicate a stronger belief in control over pain through internal factors, health professionals, or chance, depending on the subscale.
Measured: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.
Pressure Algometry
The pressure algometer is an instrument with a circular disc on which the pressure measurements are displayed (with a range of 5 kg, divided into 10 parts of half a kilogram), and a rubber tip with a circular surface of 1 cm2, which allows the pressure force to be transferred to deep tissues. The FPK 60 Analogue Algometer will be used in this study.
Its application follows the protocol proposed by another similar study. The tip of the algometer will be applied perpendicular to the muscle and a pressure will be maintained, progressively increasing at 1 kg/sec. Subjects will be instructed to make a signal at the moment they experience pain, in order to have an accurate record (pain threshold). The points where algometry will be performed are: masseter, temporalis and trapezius muscles and the suboccipital level.
Measured: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses
The SCL-90-R Symptom Inventory
This inventory was developed to assess patterns of psychosocial symptoms present in individuals, and can be used in both community tasks and clinical diagnosis. Each of the 90 items is answered on a five-point scale (0-4). It is assessed and interpreted according to nine primary dimensions and three global indices of psychological distress: (1) somatizations (SOM), (2) obsessions and compulsions (OBS), (3) interpersonal sensitivity (SI), (4) depression (DEP), (5) anxiety (ANS), (6) hostility (HOS), (7) phobic anxiety (FOB), (8) paranoid ideation (PAR), (9) psychoticism (PSIC) and other indices such as (1) global severity index (GSI), (2) total positive symptoms (TSP) and (3) positive symptomatic distress index (PSDI). In spanish population; CI=0.72-0-96, in terms of chronic pain; CI=0.78-0,97. Higher scores on this inventory indicate more significant psychosocial symptoms and distress, which may be relevant in diagnosing psychological conditions or assessing the impact of chronic pain
Measured: It will be used in the pre-intervention analysis.
Brief Coping Coping with Stress Questionnaire (COPE28)
A multidimensional inventory, developed to assess different forms of stress coping. Five of its scales (four items each) conceptually measure different aspects of problem-focused coping (active coping, planning, suppression of distracting activities, restraining coping, seeking instrumental social support). This scale has an Internal Consistency of between 0.71 and 0.80 as measured by Cronbach's alpha. Minimum score: 0 (indicating no use of the particular coping strategy). Maximum score: 4 (indicating maximum use of the coping strategy).
Measured: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.
The Perceived Stress Scale (PSS) questionnaire.
A self-report instrument that assesses the level of perceived stress over the past month, it consists of 14 items with a five-point scale response format (0 = never, 1 = hardly ever, 2 = occasionally, 3 = often, 4 = very often). The total PSS score is obtained by inverting the scores of items 4, 5, 6, 7, 9, 10 and 13 (as follows: 0=4, 1=3, 2=2, 3=1 and 4=0) and then adding the 14 items. The direct score obtained indicates that a higher score corresponds to a higher level of perceived stress. This scale has an Internal Consistency of 0.81 and a test-retest validity of 0.73. Higher scores indicate a higher level of perceived stress in the past month. Lower scores suggest that the individual has experienced lower levels of perceived stress.
Measured: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.
The Strait Anxiety Questionnaire (STAI)
A questionnaire intended to assess individuals' anxiety level. More specifically, the STAI measures individuals' predisposition to perceive various stimuli as threatening (i.e. trait anxiety). Thus, an individual with high trait anxiety is more likely to produce an anxiety response. It includes 40 items (i.e. 20 for each subscale), the response scale ranges from 0 to 3 points. In the State Anxiety subscale, item scores range from 0=not at all [not at all], 1=somewhat [somewhat], 2=quite a bit [moderately], and 3=very much [a lot]. In the Trait Anxiety subscale, response options range from 0=almost never [almost never], 1=sometimes [sometimes], 2=often [often], and 3=almost always [almost always]. Although each subscale has a theoretical range of 20 to 80, the scores can be compared with those of the original scale by adding 20 to the scores obtained.The Cronbach's alpha for this scale is 0.82. Higher scores on either subscale indicate higher levels of anxiety.
Measured: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Apr 2025
- Study start28 Nov 2025
- Primary completion24 May 2026 (estimated)
- Study completion24 May 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chronic Orofacial PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- A prospective, longitudinal, comparative randomized clinical trial (RCT) will be conducted. The sample will be composed of adults with chronic orofacial pain who meet the inclusion and exclusion criteria of the study. Three measurements will be performed: pre-intervention, post-5 weeks and post-6 months. The study is based on the principles of the 2017 Declaration of Helsinki, all participants will be informed at all times and prior to study participation will be required to sign informed consent. The intervention design has been designed based on the CONSORT Guidelines for Randomised Clinical Trials and will be registered on ClinicalTrials.gov.
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 98 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Fundación Universidad Católica de Valencia San Vicente Mártir
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06932406
- Sponsor's protocol ID
- UCV/2023-2024/072
- Status last verified
- Jan 2025
- First submitted
- 10 Apr 2025
- Last updated
- 8 Dec 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Orofacial Pain Self-management: Personality Moderation Effect - Randomized Clinical Trial
- ClinicalTrials.gov ID
- NCT06932406
- Acronym / sponsor ID
- UCV/2023-2024/072
- Conditions
- Chronic Orofacial Pain, Temporomandibular Disorder (TMD), Temporomandibular Disorders (TMD), Temporomandibular Dysfunction (TMD)
- Keywords
- Temporomandibular disorder, Orofacial pain, Self-management, self-efficacy, therapeutic exercise, therapeutic education, cognitive behavioral, mind-body techniques
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 98 participants (estimated)
- Lead sponsor
- Fundación Universidad Católica de Valencia San Vicente MártirUniversity, hospital or other
- Study start
- 28 Nov 2025 (actual)
- Primary completion
- 24 May 2026 (estimated)
- Study completion
- 24 May 2026 (estimated)
- First posted
- 17 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The objective of this clinical trial is to study the effect of self-management on pain perception in patients with chronic orofacial pain and temporomandibular disorders (TMD) comparing it with the conventional treatment proposed by the TMD clinical practice guidelines. It also evaluates its effect on function and various psychosocial variables.
As a secondary objective, this work proposes to study the variability between patients, in terms of personality factors, as moderators of the effect of treatment on pain perception. Including in the proposed statistical models certain covariates such as perception and/or coping with stress, anxiety and other psychosocial variables.
This is a randomized clinical trial with two intervention groups and three measurement times (T0; pre-intervention, T1; post-5 weeks and T2; post-6 months). The experimental group will be applied a protocol based on self-management, which includes: therapeutic education, cognitive-behavioral tools, therapeutic exercise of the temporomandibular region, mind-body strategies and modifications of aspects related to lifestyle. The control group will carry out an intervention program based on the Clinical Practice Guidelines for the Management of Temporomandibular Joint Disorders. Therefore, using a set of tools based on therapeutic education, cognitive-behavioral tools for bruxism and other parafunctional habits, temporomandibular region exercises and manual therapy.
Detailed description
Temporomandibular disorders (TMD) are the most common cause of chronic orofacial pain and encompass a range of syndromes affecting the masticatory muscles and temporomandibular joints (TMJ). Approximately 9-13% of the population experiences orofacial pain related to TMD. The high complexity, multifactorial nature, recurrence, and long duration of chronic pain increase the need for approaches focused on a multi-component management, based on learning strategies and coping skills, self-efficacy, and self-care. These approaches can be classified as self-management interventions, and their multifactorial nature makes them suitable for application and teaching by various health professionals. Within this multifactoriality, previous studies have shown that the patient's personality influences the occurrence and progression of chronic pain. The objective of this study is to evaluate a comprehensive self-management program in patients with chronic orofacial pain to assess its effect on pain perception and other psychosocial and functional variables, and subsequently analyze the moderation of factors related to the patient's personality on the intervention outcomes.
It is hypothesized that the self-management-based treatment is effective in reducing pain perception in the short and medium term, and that personality is a moderating factor for the intervention's effect.
The study will be conducted on 98 subjects aged 18 to 65, diagnosed with TMD and chronic orofacial pain. The intervention will last for 10 weeks with 5 sessions of application and 3 sessions of evaluation (pre-intervention; during the session time for the first intervention application session, post-5 weeks during the session time for the last intervention application session, and post-6 months; in an extra session dedicated solely to making the evaluation record). Each intervention session will be held once every two weeks. Results will be assessed using the EVA and GCPS questionnaires (pain), PCS (catastrophizing), TSK/TMD/S (kinesiophobia), FABQ (fear-avoidance), MFIQ (mandibular dysfunction), CPSS (self-efficacy), MMO (mandibular opening), Borg (perceived fatigue), BFQ (personality), CLCD (pain locus), COPE28 (stress coping), PSS (stress perception), STAI (anxiety), pressure algometry (pain threshold), intra-articular sound quantification, and treatment-seeking behavior.
All variables will be taken in triplicate at all three measurement times with the exception of the personality-related variable (BFQ). A descriptive statistical analysis of all variables in each of the intervention groups will be performed. To analyse the effect of the intervention on pain and the other secondary variables, a repeated-means ANOVA analysis will be performed between the self-management group (GSelfManagement) and the group based on the clinical practice guideline (GGuide). To examine whether variation in pain at follow-up is influenced by personality variables and/or the psychosocial variables kinesiophobia, catastrophising thoughts, fear-avoidance, type of pain control, perception of stress and anxiety, and stress coping, a moderation and mediation analysis will be performed. This analysis determines whether the effect size of a causal variable X (VAS and GCPS, MFIQ, MMO and VAS Fatigue) on outcome Y (GGuide and GSelfManagement), depends on a moderating or mediating variable W (i.e., kinesiophobia, catastrophizing, fear-avoidance, stress and anxiety perception, stress coping, personality and type of pain control). The degree of significance will be set at p<0.05. All analyses will be performed using statistical analysis software (SPSS 24 Inc, Chicago, Illinois, USA and The PROCESS macro for SPSS).
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 2
- Model description
- A prospective, longitudinal, comparative randomized clinical trial (RCT) will be conducted. The sample will be composed of adults with chronic orofacial pain who meet the inclusion and exclusion criteria of the study. Three measurements will be performed: pre-intervention, post-5 weeks and post-6 months. The study is based on the principles of the 2017 Declaration of Helsinki, all participants will be informed at all times and prior to study participation will be required to sign informed consent. The intervention design has been designed based on the CONSORT Guidelines for Randomised Clinical Trials and will be registered on ClinicalTrials.gov.
| Arm | Type | Receives |
|---|---|---|
| Self-management Group | Experimental | Other: Self-management interventionThis group will implement a protocol based on self-management consisting of 5 levels of strategy: educational concepts and dynamics, cognitive behavioural tools, therapeutic exercise of the orofacial region, guidelines and strategies for lifestyle modification and mindbody tools. This protocol was developed by conducting a previous Scoping Review abouts application methods of selfmanagement in orofacial region. The intervention will be carried out in 5 total sessions of 45-60 minutos over 10 weeks. |
| Clinical Practice Guideline Group | Active comparator | Other: Clinical Practice Guideline InterventionThe protocol will be based on the Clinical Practice Guideline for the Management of Temporomandibular Disorders 2021. Following the guideline, there will be 5 sessions of pathology and pain education, cognitive behavioural tools for bruxism and parafunctional habits, jaw exercises for motor control, mobility and strength, and manual therapy. The intervention will be carried out in 5 total sessions of 45-60 minutos over 10 weeks. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- The patient presents TMDs diagnosed according to the CD/TMD classification.
- Age between 18 and 65.
- Presence of pain in mandibular, temporal, facial, peri-auricular and/or auricular regions.
- Presence of chronic orofacial pain. Defined by the ICD-11 as orofacial pain or headache that occurs for more than two hours a day for 50% of the days of the last three months.
- Orofacial pain is related to TMDs according to the International Classification of Headaches.
Key exclusion criteria (6 listed)
- Concomitant rheumatic systemic pathologies.
- History of trauma or recent surgical intervention in the head, face, neck or chest.
- Presence of intraoral infections or odontogenic pain.
- Headache of neuropathic origin (trigeminal neuralgia, Arnold neuralgia, etc.).
- Being receiving therapy (except rescue pharmacological therapy) for this disorder or pain.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Self-management interventionAlso: GSelf-Management, GS-MThis intervention will implement a self-management protocol. It will consist in 5 strategy levels: educational concepts and dynamics, cognitive behavioural tools and processes, therapeutic exercise of the orofacial region, guidelines and strategies for lifestyle modification and mindbody tools. Several of the above 5 strategies will be employed in each session. Education will include TMD concepts, pain neurophysiology, contextualisation of pain in terms of perceived stress, anxiety and others. Exercises will aim to train motor control, strength and mobility. Cognitive behavioural tools will be used to modulate pain relationship through behaviour modification. Processes such as cognitive distraction, gradual exposure to movement or the scheduling of self-care activities will be used. Mindbody strategies such as relaxation exercises and pain acceptance will seek to reduce the patient's frustration with pain. Structured guidelines will be included to achieve desirable lifestyle changes. | Other | Self-management Group |
| Clinical Practice Guideline InterventionAlso: GClinical Practice Guideline, GCPGFollowing the guidelines, 5 sessions of education, cognitive behavioural tools, jaw exercises and manual therapy will be conducted. The educational sessions will teach about TMD and basic pain concepts. A single type of cognitive behavioural tool will be employed. The aim will be to decrease bruxing and parafunctional activity during wakefulness. This will be done by training the jaw relaxation position, which will then be generalised to activities of daily living with the help of some conditioning through positive and negative reinforcement. Exercise activities will aim to train motor control, strength and mobility. Manual therapy will be carried out in the orofacial region by means of soft tissue techniques and joint mobilisation. | Other | Clinical Practice Guideline Group |
Primary outcome
Visual Analogue Scale (VAS)
Time frame: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.
Pain intensity assessment instrument consisting of a 10-centimetre horizontal line numbered from 0 to 10, where 0 represents no pain and 10 represents the greatest unimaginable pain. The patient must mark on the line the point that indicates the intensity of his or her pain and then it is measured with a millimetre ruler. The intensity is expressed in centimetres or millimetres. If reporting a score on this scale, it is important to include the minimum and maximum values (0 and 10, respectively), as well as clarify that higher scores represent worse pain intensity. This tool has a high reliability, with an Internal Consistency (IC) of 0.97.
Chronic Pain Grading Scale 2.0 Spanish Version (GCPS)
Time frame: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.
Quantitative assessment scale of chronic pain that evaluates the degree of pain using 8 items, quantifying the number of days of pain in the last 6 months, current pain, average and maximum monthly pain and pain and limitation in ADL, social and occupational activities. Each item measures the score on an 11-point Likert scale, with a total range from 0 to 70 points. The tool has an internal consistency, represented by Cronbach's α coefficient, of 0.87 (95% CI, 0.83-0.92). If reporting a score on this scale, it is important to include the minimum and maximum values (0 and 70, respectively), as well as clarify that higher scores represent worse outcomes.
15 secondary outcomes
Demographic data
Time frame: These data will be collected pre-intervention.
Pain Catastrophizing Scale (PCS)
Time frame: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.
The Tampa Scale of Kinesiophobia for Temporomandibular Disorders Versión Español (TSK11-TMD-S)
Time frame: It will be used in pre-intervention, post-5 weeks and post-6 months analyses.
Fear-Avoidance Beliefs Questionnaire (FABQ)
Time frame: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.
The Mandibular Function Impairment Questionnaire (MFIQ)
Time frame: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.
Máxima apertura de la boca (MMO)
Time frame: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.
Intra-articular sounds
Time frame: To be used in pre-intervention, post-5 weeks and post-6 months analyses.
Borg Scale
Time frame: It will be collected during each of the exercise sessions to check compliance with the intensity of the exercises. The data will not be processed statistically.
Big Five Personality Test (BFQ)
Time frame: This tool will be used in the pre-intervention measurement.
Pain Locus of Control Questionnaire (CLCD)
Time frame: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.
Pressure Algometry
Time frame: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses
The SCL-90-R Symptom Inventory
Time frame: It will be used in the pre-intervention analysis.
Brief Coping Coping with Stress Questionnaire (COPE28)
Time frame: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.
The Perceived Stress Scale (PSS) questionnaire.
Time frame: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.
The Strait Anxiety Questionnaire (STAI)
Time frame: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Dec 2025.
Related trials for Chronic Orofacial Pain
RecruitingObservational study
Masticatory Muscle Activity Using a 24-Hour Wearable Device
Chronic Masticatory Myofascial Pain
Not yet recruiting
Skills Training and Relief for Orofacial Pain
Chronic Orofacial Pain, Orofacial Pain
Not yet recruiting
Marine Lipids Ease Painful TMD
Temporomandibular Disorder (TMD)
Not yet recruitingPhase 2
Full-Spectrum Cannabis Extract for Chronic Pain and Bone Health Biomarkers in Women
Chronic Pain, Fibromyalgia
Active, not recruiting
Individualized Assessment and Treatment for TMD
Temporomandibular Joint Disorders, Orofacial Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Self-management intervention and Clinical Practice Guideline Intervention in people with Chronic Orofacial Pain and Temporomandibular Disorder (TMD), run by Fundación Universidad Católica de Valencia San Vicente Mártir at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 8 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Marta M Martínez-Soler, Physiotherapist (+34 638 97 48 04, marta.martinez@ucv.es), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Visual Analogue Scale (VAS) (time frame: It will be used in the pre-intervention, post-5 weeks and post-6 months analyses.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Dec 2025.